Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emilio Perucca

Showing results (241-250 of 306) with videos related to

Pageof 31
Sort By:
Epilepsia|August 22, 2021
A web-based algorithm to rapidly classify seizures for the purpose of drug selectionSándor Beniczky, Ali A Asadi-Pooya, Emilio Perucca, et al.
Epilepsy Research|September 3, 2010
Patterns of prescription of antiepileptic drugs in patients with refractory epilepsy at tertiary referral centres in ItalyAmbra Malerba, Clotilde Ciampa, Salvatore De Fazio, et al.
Regulatory Toxicology and Pharmacology : RTP|February 24, 2023
Proposal for reference values for the developmental effects of valproate based on human data using a benchmark dose approachIsabelle Manière-Guerrero, Erminio Bonizzoni, Dina Battino, et al.
Epilepsy & Behavior : E&B|January 2, 2019
Perinatal outcome and healthcare resource utilization in the first year of life after antiepileptic exposure during pregnancyDaria Putignano, Antonio Clavenna, Rita Campi, et al.
Epilepsy Research|January 7, 2004
Adjunctive therapy versus alternative monotherapy in patients with partial epilepsy failing on a single drug: a multicentre, randomised, pragmatic controlled trialEttore Beghi, Giuliana Gatti, Clara Tonini, et al.
Epilepsia Open|March 7, 2025
Interim analysis of the long-term efficacy and safety of azetukalner in an ongoing open-label extension study following a phase 2b clinical trial (X-TOLE) in adults with focal epilepsyJacqueline A French, Roger J Porter, Emilio Perucca, et al.
Epilepsia|February 6, 2010
Characteristics of a large population of patients with refractory epilepsy attending tertiary referral centers in ItalyVeriano Alexandre, Giuseppe Capovilla, Cinzia Fattore, et al.
Epilepsia|May 29, 2014
Long-term safety of perampanel and seizure outcomes in refractory partial-onset seizures and secondarily generalized seizures: results from phase III extension study 307Gregory L Krauss, Emilio Perucca, Elinor Ben-Menachem, et al.
Epilepsia|December 27, 2018
Do neurologists agree in diagnosing drug resistance in adults with focal epilepsy?Gaetano Zaccara, Marco Mula, Bruno Ferrò, et al.
Epilepsia|April 10, 2008
Antiepileptic drugs--best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic StrategiesPhilip N Patsalos, David J Berry, Blaise F D Bourgeois, et al.
Pageof 31

Showing results (241-250 of 306) with videos related to

Sort By:
Pageof 31
Epilepsia|August 22, 2021
A web-based algorithm to rapidly classify seizures for the purpose of drug selectionSándor Beniczky, Ali A Asadi-Pooya, Emilio Perucca, et al.
Epilepsy Research|September 3, 2010
Patterns of prescription of antiepileptic drugs in patients with refractory epilepsy at tertiary referral centres in ItalyAmbra Malerba, Clotilde Ciampa, Salvatore De Fazio, et al.
Regulatory Toxicology and Pharmacology : RTP|February 24, 2023
Proposal for reference values for the developmental effects of valproate based on human data using a benchmark dose approachIsabelle Manière-Guerrero, Erminio Bonizzoni, Dina Battino, et al.
Epilepsy & Behavior : E&B|January 2, 2019
Perinatal outcome and healthcare resource utilization in the first year of life after antiepileptic exposure during pregnancyDaria Putignano, Antonio Clavenna, Rita Campi, et al.
Epilepsy Research|January 7, 2004
Adjunctive therapy versus alternative monotherapy in patients with partial epilepsy failing on a single drug: a multicentre, randomised, pragmatic controlled trialEttore Beghi, Giuliana Gatti, Clara Tonini, et al.
Epilepsia Open|March 7, 2025
Interim analysis of the long-term efficacy and safety of azetukalner in an ongoing open-label extension study following a phase 2b clinical trial (X-TOLE) in adults with focal epilepsyJacqueline A French, Roger J Porter, Emilio Perucca, et al.
Epilepsia|February 6, 2010
Characteristics of a large population of patients with refractory epilepsy attending tertiary referral centers in ItalyVeriano Alexandre, Giuseppe Capovilla, Cinzia Fattore, et al.
Epilepsia|May 29, 2014
Long-term safety of perampanel and seizure outcomes in refractory partial-onset seizures and secondarily generalized seizures: results from phase III extension study 307Gregory L Krauss, Emilio Perucca, Elinor Ben-Menachem, et al.
Epilepsia|December 27, 2018
Do neurologists agree in diagnosing drug resistance in adults with focal epilepsy?Gaetano Zaccara, Marco Mula, Bruno Ferrò, et al.
Epilepsia|April 10, 2008
Antiepileptic drugs--best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic StrategiesPhilip N Patsalos, David J Berry, Blaise F D Bourgeois, et al.
Pageof 31